TrumpRx Drug Pricing Initiative

President Trump launched TrumpRx on Feb. 5, 2026 (7 p.m. EST), a drug‑discount website that lists 43 discounted prescription products and links consumers to manufacturers’ direct‑to‑consumer sites rather than processing purchases or billing insurers. Tied to more than a dozen “most favored nations” pricing deals with major drugmakers (AstraZeneca, Eli Lilly, Genentech, Merck, Pfizer, etc.), the site offers cash‑pay prices — for example Wegovy at $149/month vs. a $1,349 list price and an 83% discount on Gonal‑F — but those purchases don’t count toward insurance deductibles and may not routinely beat insured patients’ costs, with future insurance coverage tied to the administration’s proposed “Great Healthcare Plan.”